Co‐endemicity of schistosomiasis and tegumentary leishmaniasis: Spatial co‐clustering in endemic areas
Authors:
- Genil Mororó Araújo CameloGCGenil Mororó Araújo Camelo
- Jeferson Kelvin Alves de Oliveira SilvaJSJeferson Kelvin Alves de Oliveira Silva
- Dharliton Soares GomesDGDharliton Soares Gomes
- Laura MaggiLMLaura Maggi
- Stefan Michael GeigerStefan Michael Geiger
- David Soeiro BarbosaDBDavid Soeiro Barbosa
- Deborah Aparecida Negrão‐CorrêaDNDeborah Aparecida Negrão‐Corrêa
Open Access
- 27 April 2025
- journal article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 30 (6) , 556-568
Abstract
Objectives: Schistosomiasis and tegumentary leishmaniasis simultaneously affect areas in tropical and subtropical regions. Co‐infected individuals show a less‐than‐optimal response to treatment and increased regulatory immune responses. However, no study has determined where Schistosoma–Leishmania co‐infections are more likely to occur.Methods: Data from The Global Health Observatory were collected to determine the worldwide endemicity status of schistosomiasis and tegumentary leishmaniasis in 2023. To determine co‐endemic areas at a local level, an ecological study was conducted on confirmed cases of American tegumentary leishmaniasis and schistosomiasis in the State of Minas Gerais, Brazil, between 2013 and 2017. Local Indicators of Spatial Association analyses were used to search for co‐endemic hotspots.Results: Thirty‐one countries were considered co‐endemic, 23 of which presented active transmission of both diseases. Univariate Local Indicators of Spatial Association indicated 13 municipalities as high–high clusters for both American tegumentary leishmaniasis and schistosomiasis in Minas Gerais. Furthermore, bivariate Local Indicators of Spatial Association analyses identified 61 municipalities as high–high clusters, grouped in seven co‐endemic hotspots.Conclusion: Local Indicators of Spatial Association analyses are a useful tool for identifying areas where co‐infection cases are more likely to occur. Similar analyses will assist authorities and healthcare providers when formulating policies and treating Schistosoma–Leishmania co‐infected patients and will provide valuable data to enable researchers to explore the impact of this and other co‐infections.Keywords
This publication has 79 references indexed in Scilit:
- Human schistosomiasis in Nigeria: present status, diagnosis, chemotherapy, and herbal medicinesParasitology Research, 2023
- Impact of the COVID-19 pandemic on the actions of the Schistosomiasis Control Program in an endemic area in Northeastern BrazilActa Tropica, 2023
- Cutaneous Leishmaniasis: A 2022 Updated Narrative Review into Diagnosis and Management DevelopmentsAmerican Journal of Clinical Dermatology, 2022
- Spatiotemporal patterns of cutaneous leishmaniasis in the district upper and lower Dir, Khyber Pakhtunkhwa, Pakistan: A GIS-based spatial approachesActa Tropica, 2021
- Intestinal helminth coinfection is associated with mucosal lesions and poor response to therapy in American tegumentary leishmaniasisActa Tropica, 2016
- Effect of different stages of Schistosoma mansoni infection on the parasite burden and immune response to Strongyloides venezuelensis in co-infected miceParasitology Research, 2015
- Spatial analysis for identification of priority areas for surveillance and control in a visceral leishmaniasis endemic area in BrazilActa Tropica, 2014
- Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD miceEuropean Journal of Immunology, 2009
- The effect of the number of stool samples on the observed prevalence and the infection intensity with Schistosoma mansoni among a population in an area of low transmissionActa Tropica, 2008
- Variations in helminth faecal egg counts in Kato–Katz thick smears and their implications in assessing infection status with Schistosoma mansoniActa Tropica, 2004